ShreyaChablaneyMD

Gastroenterology • New York, NY

Esophagus Disease

Gastroenterologist focusing on Esophageal Diseases

Join to view full profile

Dr. Chablaney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chablaney's full profile

Already have an account?

Office
240 E 38th Street
23rd Floor
New York, NY 10016
Phone+1 212-263-3095

Fax+1 212-263-3096

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Gastroenterology, 2019 - 2022
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2016 - 2019
George Washington University School of Medicine and Health SciencesClass of 2016

Certifications & Licensure

NY State Medical License 2018 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Publications & Presentations

PubMed

Correction: Risk factors associated with functional esophageal disorders (FED) versus gastroesophageal reflux disease (GERD).
Moniyka Sachar, Marina Mautner Wizentier, Emma Risner, Hannah Asmail, Mathew Omara
Surgical Endoscopy. 2024-05-01
1 citations
Risk factors associated with functional esophageal disorders (FED) versus gastroesophageal reflux disease (GERD).
Moniyka Sachar, Marina Mautner Wizentier, Emma Risner, Hannah Asmail, Mathew Omara
Surgical Endoscopy. 2024-05-01
32 citations
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
Dana J. Lukin, David Faleck, Ronghui Xu, Yiran Zhang, A Weiss
Clinical Gastroenterology and Hepatology. 2020-10-08